AI technology from Clinithink has helped diagnose a rare disease in the newborn, saving its life
AI applications to health care continue to grow – recent advances have included the use of algorithms to detect cancerous skin lesions, and to identify areas where there may be a complete increase in mental health impairment in humans.
Now comes the news from Cllinithink, an AI healthcare expert, that its software has helped identify a rare genetic disorder in a very sick newborn, which saves its life. Doctors from the American Rady Children’s Institute for Genomic Medicine (RCIGM) have published a book in the New England Journal of Medicine (NEJM) explaining how they did the diagnosis.
The RCIGM team has used AI technology as part of their Whole Genome Sequicing (WGS) approach. This includes the use of CLiX, an AI software developed by Clinithink to give health professionals a human understanding.
The five-week-old baby was born healthy, but began to feel unwell and was admitted to the intensive care unit at Rady Children’s Hospital-San Diego.
Tests show that you have encephalopathy, a condition that affects the brain that can be caused by a variety of problems, from diseases such as meningitis to brain tissue.
When a child’s condition worsens and he often fits, the clinic team performs a genome sequence to check for genetic support. Given that a child’s brain is affected, prompt diagnosis and treatment were essential to prevent long-term neurological damage, or even death. The team used CLiX to complete in-depth phenotyping, a type of patient symptom analysis and clinical findings to compare with more than 12,000 phenotypes known to be associated with more than 7000 rare diseases. This complements genomic data and is important in confirming diagnosis, but it is usually done by hand and can take hours if not, even if it is done by trained genes.
CLiX has enabled this to be done in one minute, helping the team achieve a diagnosis of 13.5 hours in total. The diagnosis was thiamine metabolism dysfunction syndrome 2 (THMD2), a rare disease that can be treated effectively with vitamin supplements if diagnosed early.
Treatment was started, and the child was able to leave the hospital after three days; he is now thriving at seven months of age.
“Naturally we are very pleased that the team at RCIGM has been able to bring about such an important outcome for this patient using their pioneering approach to the diagnosis of a rare disease that includes the focus of CLIX” said Chris Tackaberry, CEO and Founder of Clinicink.
“As a healthcare professional, it is amazingly encouraging to know that the software we produce can help make this kind of difference at the end of the clinic. That’s why we came to work,” he added.
In addition to RCIGM, Clinithinkink AI technology is used at UK’s Barts Hospital and Newcastle upon Tyne Hospital NHS Foundation Trust.Johns Hopkins All Children’s Hospital appoints K. Alicia Schulhof as President
Johns Hopkins All Children’s Hospital in Baltimore has elected its first female president and K. Alicia Schulhof, who joins Peyton Manning Children’s Hospital in Indianapolis. Schulhof has spent more than 17 years leading health organizations including Indiana University Health and HCA Healthcare.
Prior to joining Indiana University Health, Schulhof served in the Tampa Bay region as Chief Operating Officer, and Ethics and Compliance Officer for Brandon Regional Hospital.
“Johns Hopkins All Children’s Hospital is a beacon of hope and treatment in the region and across the country,” Schulhof said. “I look forward to meeting with the Tampa Bay community and assisting a diverse group of doctors and staff at Johns Hopkins All Children’s Hospital to continue building the future of children’s lives through research and clinical practice.”
Talkiatry is hiring Jared Camins as the new CTO
Starting mental health Talkiatry has appointed Jared Camins as Chief Technology Officer, as the demand for mental health care continues to grow. Chems joins Talkiatry from Lively, where he leads the team in charge of building the company’s mobile platform. Prior to this he played a major role in the engineering teams at Cityblock Health and Remedy Partners.
As the CTO of Talkiatry, you will be responsible for implementing the technical concept of Talkiatry and overseeing the construction of its interactive platform.
“The need for mental health care is at an all-time high and there is a shortage of people,” said Robert Krayn, CEO and Co-Founder of Talkiatry. “Jared’s expertise and leadership will further advance Talkiatry’s focus on rehabilitating mental health care and addressing the long-standing challenges the industry faces in providing adequate care.”
Jean-Olivier Racine joins Outset as CTO
Jean-Olivier Racine joins Outset Medical, a medtech company behind Tablo, a dialysis program that has been phased out by the FDA for use at home.
Racine has more than two decades of experience in the technology industry. As Head of Engineering and Health Science AI at Amazon Web Services, he manages Amazon Comprehend Medical and Amazon HealthLake. Prior to joining Amazon, Racine spent more than a decade in software engineering at companies such as the Toronto Stock Exchange (TMX), NexGen Ergonomics, and the Canadian Department of Defense.In this new role, Racine will look at Outset’s product technology strategy. “I was drawn to join Outset Medical because of the great opportunity the dialysis industry brings, especially in terms of using technology and AI in developing new forms of care,” he said. “I look forward to using my expertise to build on the good work that Outset has done with Tablo, as well as to create new services for patients and providers as we move forward in the future given technology.”
Jack Nathan Health appoints Michael A. Pangia as Strategic Advisor
Canadian healthcare provider Jack Nathan Health has hired Michael A. Pangia to be a strategic advisor. Pangia had previously served as President and Chief Executive Officer of Aviat Networks, and had held various leadership positions in charge of sales, finance, resources and operations, while serving as a key member of Nortel Networks’ leadership team.
Through his contribution to Jack Nathan Health, Pangia will provide top management in the company’s programs while working in partnership with a team of leaders. His main focus will be on supporting the expansion of the company, and establishing new relationships to provide the company with financial flexibility as it grows.
Pangia said: “I believe the Company has great potential to be a leading player in the consumer markets, while continuing to expand its track record with services. This is the company’s place and I will do everything I can to bring value to the Jack Nathan Health team and its shareholders.”
Quantgene employs David Herrmann as Chief Commercial Officer
German biotechnology, cloud and AI company Quantgene has appointed David Herrmann as Chief Commercial Officer. Herrmann previously worked as Global Head of Digital Solutions at Johnson & Johnson Medtech, and CEO of C-SATS, a Johnson & Johnson software company in the area of ??digital health data and AI space.
With this position Quantgene expands its leadership team, assisting it in its goal of extending healthy human health by ten years within ten years. a leader in the space of a tree with precision. I am excited to be a part of building this future for doctors and patients, ”said Herrmann.Steeve Huin, CMO in Irdeto, explains how the IoMT industry can protect itself from cyber attacks in the world after COVID
The adoption of technology in the healthcare industry is increasing at an alarming rate by 2020 and as a result, the number of connected medical devices – an integral part of the Internet of Things (IoMT) – is thriving. The COVID-19 epidemic has redefined the use of medical devices, increasingly used by patients in their homes.
A recent report by Mordor Intelligence predicts that the market for connected medical devices will be a balloon from $ 28 billion by 2020 to $ 94 billion by 2026. This rapid growth offers significant opportunities for medical device manufacturers, digital healthcare companies, healthcare providers, and patients as the industry advances consumer-focused, customized and technology-focused care model. However, the growing use of connected medical devices to improve patient care has been overshadowed by the fact that IoMT devices are at greater risk of cyber attacks as the previous year proved.
Cyberattacks on IoT devices have tripled in 2019 alone, accounting for more than 2.9 billion events. Frost & Sullivan estimates that 20 million to 30 million IoT and medical devices will be part of the health system before the end of 2020, and it is estimated that at least 50 billion medical devices will be connected to clinical systems in the next ten years. The proliferation of connected devices and the growing attacks are making the IoMT industry a real target for hackers.
Stealing medical records is of great benefit to hackers. In fact, health records are currently the most important asset identification (PII) item sold by cyber criminals. Medical records often include social security, financial and other information numbers and provide the most comprehensive picture of a person’s background and identity today, and can be sold on the black web to fraudsters, human traffickers, terrorist organizations, hostile countries, drug dealers, and more than $ 1,200 for each record. In fact, medical records are 50 times more important than credit card numbers.
When cyber attacks are successful, patients and health care providers are at risk of disruption of care, identity theft, financial fraud, and other forms of crime. They are incredibly expensive in health care organizations, both from a financial point of view and from a reputation. Violations of health care data in the US cost an estimated $ 7.13 million by 2020, including a country-wide regulatory penalty – a 10% increase from 2019 and more than any other sector. With the growing use of connected medical devices, cyber security must be put first. Unfortunately, the rapid change in connected health care is a major challenge for medtech professionals around the world.
IoMT administrators are not prepared for cyber attacks
While cyberattack can have far-reaching consequences, the IoMT industry will still be very active in cyber security. According to a recent study conducted by Irdeto, in collaboration with Censuswide and Guidepoint Global, only 13% of IoMT leaders say they believe their business is best prepared to reduce future security risks, while 70% believe they are somehow prepared. Shockingly, nearly one in five (17%) said their company was not prepared at all.The data also show that 80% of study participants reported having suffered at least one cyberattack over the past five years, and are sure to face many additional threats every day. Organizations have also been the victim of a number of attack tactics, including ransomware, malware, identity theft, spoofing and DDoS, and customer information, employee information and R&D forums being exploited.
In addition, only 4 out of 10 respondents did not know how much they knew about the upcoming EU and US regulations, and 28% reported not knowing anything about future regulations. This is related to, in view of the rapidly changing regulation in both regions.
How the IoMT industry can protect itself from cyber security threats
With the magnitude and magnitude of the threats facing connected medical devices, professionals working in the IoMT industry must apply cyber security management. This starts with building a complete cyber security strategy that includes three key elements:
It is important to protect the software running on medical devices, as software applications become an integral part of the attack and unprotected applications can leave a trail that can be undone to disrupt the visual care platform. These protections should be built on devices during the construction process where possible. Bonding cyber security when a product is already on the market is very difficult and often inadequate. This includes conducting a risk performance analysis, identifying any assets or activities that threaten potential actors, and burning them during the development phase. It helps to keep a list of safety requirements to be applied to products to make this process easier and more efficient.
Connected medical devices need to continue to be managed once they are out of the market. This includes ensuring that the devices are up to date with the latest software versions and keeping pace with market changes. Currently the most important technologies in the post-COVID world are those that protect sensitive data, can be repackaged or harassed, and ensure that the software remains a black box for attackers.
Finally, the response process is a key element of the cyber security system. If there is a problem, it is important to be able to handle it quickly. The accountability system should set out how to reach customers through pre-established channels and install updates if necessary
There is no such thing as a “single and personalized” cyber security. Despite existing protections, companies in the healthcare industry must continue to monitor threats, keep up with industry advances, and monitor their cyber security systems to ensure they are up to date. In this situation, IoMT participants cannot successfully design without cyber security to protect the most sensitive data and devices from malicious characters who want to access it and corrupt it in order to gain it. Ensuring the of connected medical devices is important, and will take ongoing concerted effort across the entire industry.